Impaired cell-mediated immunity in patients with classic hemophilia.
about
The lymph node in HIV pathogenesisLymphocyte subset ratios and factor VIII usage in haemophilia.Chronic immune thrombocytopenic purpura in hemophilia A.Disseminated coccidioidomycosis in a patient with acquired immune deficiency syndrome.Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.The retinal lesions of the acquired immune deficiency syndromeMucosal immunity in the female genital tract, HIV/AIDSImmunologic findings in healthy Haitians in Montreal.Defective postbinding lysis underlies the impaired natural killer activity in factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacsDeficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropicAIDS: acquired immunodeficiency syndrome. 1983Immunologic studies in asymptomatic hemophilia patients. Relationship to acquired immune deficiency syndrome (AIDS).Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells.AIDS: acquired immunodeficiency syndromeAutopsy pathology in the acquired immune deficiency syndrome.Hematologic and oncologic complications in the critically ill child.Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome.Back to the future: a recent history of haemophilia treatment.Unusually high incidence of tuberculosis among boys with haemophilia during an outbreak of the disease in hospitalHaemophilia and T lymphocyte subsets.Acquired immune deficiency syndrome: an overview of central nervous system complications and neuropsychological sequelae.Multiple pyarthrosis in human immunodeficiency virus-infected hemophiliacs.Interleukin 2 augmentation of natural killer cell activity in homosexual men with acquired immune deficiency syndrome.Acquired immune deficiency syndrome. A deadly new disease.AIDS: an update.Epstein-Barr (EB) virus infection in homosexual men in London.AIDS and the use of blood components and derivatives: the Canadian perspectiveImpaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?Serial studies of T-lymphocyte subpopulations in HIV seropositive haemophiliacs.Human T-cell leukemia virus (HTLV-I) p24 antibody in New York City blood product recipients.Twenty-one years of haemophilia.The effects of a comprehensive self-hypnosis training program on the use of factor VIII in severe hemophilia.Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis.Polyclonal T cell elimination by prolonged immunostimulation in an experimental model.Pathology of suspected acquired immune deficiency syndrome in children: a study of eight cases.
P2860
Q24644783-76BCEBFB-448B-4243-A7E7-D7B147D132BEQ33458409-923F7261-4948-498A-9FA4-F10738644796Q33480708-8CF21BCA-D015-4705-8F13-A2FACC23E932Q33606093-D3D3C59B-6039-43A6-B530-EA8A3D5FB958Q33867535-C17412B2-E240-48E8-A315-141DC4521B83Q34020126-FB1BEC4F-5E00-4E96-9707-BEDAE9518C95Q34164731-D930D45F-4E18-467F-8DCE-CC38E58BB631Q34275424-82B3ACE6-3244-4F3B-8419-50544DDCC809Q34300682-98E38A1E-CC02-42C8-9669-FD75E12B5EA4Q34572991-A325B72E-0C92-485C-BA45-829FB09785A2Q34629604-20A1EF4A-BA94-4E84-8637-46E7633A03B6Q34713698-C789B87C-F014-4BBC-8EC0-9BD050BDE5AAQ35207404-27E61274-6A5B-4F50-ACAC-3572EA5A5404Q35580662-D9D24348-0876-4046-A7E9-86B6885B574BQ35805221-B61A2D65-2A93-4B8D-95C8-13DD222DBA06Q35886035-4C8DAB6B-CCA5-4C90-9CAB-6301B4948D0DQ36988724-4C5DF916-2EF7-471E-A4AF-4E90246B17E7Q36993045-6B174271-8FBF-4067-9549-693DA22E6627Q37176481-799CB207-0E94-4DDD-9826-9A9FD4100432Q37196892-62CE2997-EF4A-4EB2-858B-8097887A017DQ38945735-698CC13B-FAD1-4C1A-8F02-2A667BCA129EQ39751813-017F5191-2B48-4F2F-9098-4F947AB51183Q40143840-E6494C84-F787-49F0-BF3C-06760F300A00Q40178055-4A55B2AE-6750-4081-985B-A2796074538FQ40834465-CB7EB030-1705-4049-9BFC-1004DC130B30Q41570569-F2312D0E-0516-4A28-967E-F9B7913DA709Q41856318-FE32710B-BBFF-411D-B16E-E9CD3396A29BQ42395734-3161530D-1285-4F13-B29F-997C51E2DBA5Q42614451-D59F7950-F9EC-4ED4-8133-0DE702C610BBQ42846771-AEFFDAAC-C273-4BF7-90CD-B82BC5200CF3Q45006308-C5506041-E118-49E0-A925-F915A6DDEDD1Q45149598-096F6553-CC03-489C-87D3-239EBE530072Q45886252-316D1118-E596-48BA-905F-0F10C14FEA34Q45886800-ADB30D67-7E96-4088-BB77-CB667B82115CQ50130203-22B39E8D-3B59-4970-BFB4-4ABB56F2F254Q50132868-B280A3EA-CFE6-4BA0-811A-AB5328E00FDBQ54135221-D0523963-8901-4BB2-B53C-D52F91A3CFB3
P2860
Impaired cell-mediated immunity in patients with classic hemophilia.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Impaired cell-mediated immunity in patients with classic hemophilia.
@en
Impaired cell-mediated immunity in patients with classic hemophilia.
@nl
type
label
Impaired cell-mediated immunity in patients with classic hemophilia.
@en
Impaired cell-mediated immunity in patients with classic hemophilia.
@nl
prefLabel
Impaired cell-mediated immunity in patients with classic hemophilia.
@en
Impaired cell-mediated immunity in patients with classic hemophilia.
@nl
P2093
P1476
Impaired cell-mediated immunity in patients with classic hemophilia.
@en
P2093
Lederman MM
Ratnoff OD
Schacter B
Scillian JJ
P356
10.1056/NEJM198301133080205
P407
P577
1983-01-01T00:00:00Z